Results 251 to 260 of about 1,275,927 (291)

Immunocompromised Hosts

2019
Abstract Infections in immunocompromised patients may occur in the clinical setting of neutropenia, B-cell and T-cell deficiencies, immunoglobulin deficiencies, complement deficiencies, and leukocyte dysfunction. Some patients have multiple defects due to both the underlying disease and its treatment.
Elena Beam, Pritish K. Tosh, M. Rizwan Sohail   +2 more
openaire   +1 more source

Lung biopsy in immunocompromised hosts

The American Journal of Medicine, 1975
Ninety-five lung biopsy procedures in 78 immunocompromised patients yielded treatable diagnoses in 35 per cent of the needle aspirates, 46 per cent of the cutting needle biopsies and 65 per cent of the open thoracotomies. Complication rates of bleeding or pneumothorax were comparable to those previously described in nonimmunocompromised patients.
R L, Greenman, P T, Goodall, D, King
openaire   +2 more sources

[An immunocompromised host with a fever].

Nederlands tijdschrift voor geneeskunde, 2010
A 61-year-old woman with a hepatocellular carcinoma was admitted to the hospital for transplantation of the liver. She had a compromised immune system and developed a aspergillus pneumonia. The patient eventually died due to sepsis and multiple organ failure.
Witjes, Carlijn, Kazemier, G
openaire   +2 more sources

GASTROINTESTINAL INFECTIONS IN THE IMMUNOCOMPROMISED HOST

Infectious Disease Clinics of North America, 2001
Gastrointestinal disease is a significant cause of morbidity and mortality in the immunocompromised patient. This article focuses on the infectious gastrointestinal complications associated with the treatment of malignant disease and with solid organ transplantation but not HIV.
L R, Baden, J H, Maguire
openaire   +2 more sources

CT of the Gut in the Immunocompromised Host

Radiologic Clinics of North America, 1989
The spread of the acquired immunodeficiency syndrome, the increasing popularity of bone marrow, renal, and other organ transplants, and the development of potent immunosuppressive drugs have produced a large population of immunocompromised hosts. These patients are at great risk for developing both opportunistic infections and neoplasms such as Kaposi ...
B, Jones, E K, Fishman
openaire   +2 more sources

Gastrointestinal mucormycosis in immunocompromised hosts

Mycoses, 2015
SummaryInvasive mucormycosis is a rare fungal infection in immunocompromised hosts, but it carries a high mortality rate. Primary gastrointestinal disease is the least frequent form of presentation. Early diagnosis and treatment are critical in the management; however, symptoms are typically non‐specific in gastrointestinal disease, leading to delayed ...
M Veronica, Dioverti, Kelly A, Cawcutt, Maheen, Abidi, M Rizwan, Sohail, Randall C, Walker, Douglas R, Osmon   +5 more
openaire   +2 more sources

Oral infections in the immunocompromised host

Seminars in Cutaneous Medicine and Surgery, 1997
The prevalence of infections in the immunocompromised host is increasing. The oral cavity is a primary or sole site in many cases. It is important for the practicing clinician to recognize the more common infections in this growing patient population.
G W, Mirowski, J D, Bettencourt, A F, Hood   +2 more
openaire   +2 more sources

The Immunocompromised Host

1990
An immunocompromised host is an individual whose immune defense mechanisms are impaired. This may be due to decreased antibody formation (B lymphocyte function), cell-mediated immunity (T lymphocyte function), granulocyte function, or a combination of these.
openaire   +1 more source

Managing cryptococcosis in the immunocompromised host

Current Opinion in Infectious Diseases, 2008
Expanding access to antiretroviral treatment has dramatically improved the long-term prognosis of patients with HIV-associated cryptococcal disease who survive the acute infection. However, the incidence and acute mortality of HIV-associated cryptococcal meningitis remain high.
Joseph N, Jarvis, Francoise, Dromer, Thomas S, Harrison, Olivier, Lortholary   +3 more
openaire   +2 more sources

Lymphoma and the Immunocompromised Host

New England Journal of Medicine, 1979
A H, Filipovich, B D, Spector, G, Frizzera, J H, Kersey   +3 more
openaire   +2 more sources